March 12, 2025 Experience Endo divestiture of International Pharmaceuticals business We are advising Endo on the transaction
November 12, 2024 Experience GSK strategic alliance with Vesalius Therapeutics We advised GSK on the transaction
July 29, 2024 Experience GSK collaboration with Flagship Pioneering We are advising GSK on the transaction
May 13, 2024 Experience AC Immune exclusive option and license agreement with Takeda Pharmaceuticals We advised AC Immune on the transaction
February 5, 2024 Experience Novo Nordisk acquisition of certain Catalent sites from Novo Holdings We are advising Novo Nordisk on the acquisition
December 21, 2023 Experience GSK exclusive license agreement for HS-20093 with Hansoh Pharma We advised GSK on the transaction
October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
October 30, 2023 Experience GSK collaboration extension and new data licensing agreement with 23andMe We advised GSK on the transaction
July 28, 2023 Experience BMS $35 million investment in Immatics We advised Immatics on the private placement of ordinary shares
June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera